Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shari Adams"'
Autor:
Shaked Lev‐Ari, Michael Serzan, Tianmin Wu, Andrew Ip, Lauren Pascual, Brittany Sinclaire, Shari Adams, Michael Marafelias, Lakshmi Ayyagari, Sarvarinder K. Gill, Barbara Ma, Jacob P. Zaemes, Alexandra Della Pia, Adil Alaoui, Subha Madhavan, Anas Belouali, Andrew Pecora, Jaeil Ahn, Michael B. Atkins, Neil J. Shah
Publikováno v:
Cancer. 129:1885-1894
Autor:
Brittany A Sinclaire, Emily Tonti, Jaeil Ahn, Jordan Kaufman, Divya Cheruku, Adil Alaoui, Michael B. Atkins, Shaked lev-Ari, Andrew L. Pecora, Elli Gourna Paleoudis, Kanchi Krishnamurthy, Michael T Serzan, Andrew Ip, Eric Muller, Shari Adams, Sahil Parikh, Neil J. Shah, Shuo Wang, Aquino Williams, Melinda Weber
Publikováno v:
Journal of Clinical Oncology. 39:2635-2635
2635 Background: Immune Checkpoint Inhibitors (ICIs) are associated with unique immune-related adverse events (irAEs). IrAEs can occur at any timepoint of ICI treatment. Late irAEs are not well reported in the literature. Herein, we attempt to charac
Autor:
Brittany A Sinclaire, Shuo Wang, Michael T Serzan, Andrew Ip, Divya Cheruku, Emily Tonti, Neil J. Shah, Aquino Williams, Jordan Kaufman, Adil Alaoui, Elli Gourna Paleoudis, Jaeil Ahn, Sahil Parikh, Melinda Weber, Shari Adams, Michael B. Atkins, Andrew L. Pecora, Shaked lev-Ari, Eric Muller
Publikováno v:
Journal of Clinical Oncology. 39:2641-2641
2641 Background: Immune Checkpoint Inhibitors (ICI) have revolutionized current cancer treatment. Nevertheless, outcomes data across various patient cohorts are lacking. To address this knowledge gap, we conducted a comprehensive analysis of real-wor
Autor:
Mark N. Stein, Austin Doyle, Christian Gable, Robert S. DiPaola, Joseph Aisner, Rebecca A. Moss, Pamela Scott, Jane Fischer, Darlene Gibbon, Antoinette R. Tan, Shari Adams, Janice M. Mehnert, Amanda Kaveney
Publikováno v:
Journal of Clinical Oncology. 32:TPS2640-TPS2640
TPS2640 Background: AKT is a frequently hyperactivated oncogenic kinase in human cancers (Degenhardt 2006). Inhibition of AKT activates autophagy, promoting tumor survival, and hence AKT inhibitors...
Autor:
Mark N. Stein, Eileen White, Pamela Scott, Diana Lindquist, Joseph Aisner, Janice M. Mehnert, Xiaoqi Xie, Hongxia Lin, Naoko Takebe, Minh-Thu Tran, Danny Ju Yong Koh, Nataliya Melnyk, Pamela Jo Harris, James M. Cleary, Darlene Gibbon, Megha Rajpal, Antoinette R. Tan, Shari Adams, Robert S. DiPaola, Rebecca A. Moss
Publikováno v:
Journal of Clinical Oncology. 31:2553-2553
2553 Background: Angiogenesis inhibitors promote autophagy, a response to nutrient deprivation in which autophagosomes (AP) and lysosomes fuse to recycle intracellular constituents, leading to sustained tumor viability. We hypothesized that the VEGF-
Autor:
Antoinette R. Tan, Shari Adams, Mark N. Stein, Mikel Ross, Joseph Aisner, Darlene Gibbon, James S. Goydos, Yvonne Wen, Rebecca A. Moss, Neha Semlani, Janice M. Mehnert, John Wright, Michael P. Kane, Suzie Chen
Publikováno v:
Journal of Clinical Oncology. 30:TPS3112-TPS3112
TPS3112 Background: Metabotropic glutamate receptor 1 (GRM1) has been identified as a potential therapeutic target in melanoma. Over 60% of human melanomas express this cell surface glutamate receptor and excitation of GRM1 results in the activation